GSMA
The GSMA today announced that the Asia Mobile Awards (AMO Awards) at MWC19 Shanghai are open for entry. Judged by a panel of leading independent industry experts, the AMO Awards honour the greatest achievements and innovations across the Asian mobile industry. Comprising 10 awards over six categories, the 2019 AMO Awards will be presented during MWC19 Shanghai, which will be held 26 – 28 June at the Shanghai New International Expo Centre (SNIEC). Entries for the AMO Awards will be accepted until Wednesday,10 April 2019.
“Asia is a leading centre of innovation, driving new developments across the broad mobile ecosystem,” said John Hoffman, CEO, GSMA Ltd. “The AMO Awards will recognise the companies and individuals that are leading this innovation on a global basis and we look forward to a wide range of exciting entries for 2019.”
The AMO Awards reflect the constant evolution of the mobile industry in Asia and put a spotlight on the latest trends shaping the industry. The 2019 AMO Awards will include 10 awards presented within the following six categories:
Mobile Technology: This award category will recognise the companies that are revolutionising the capabilities and reach of mobile and digital technologies. This year, the category will include a new award recognising the pioneers pushing the boundaries of innovation in the emerging 5G era:
- Best Mobile Technology Breakthrough in Asia
- Best IoT Innovation for Mobile Networks in Asia
- Best Smartphone in 2019
- Asia 5G Innovation Award (new in 2019)
Consumer: As consumers migrate to the connected age, this category will honour companies that have redefined the business-to-consumer relationship to enhance everyday life.
- Best Mobile Service for Connected Living in Asia
Fourth Industrial Revolution: This award category will distinguish key companies at the forefront of the digital shift, across seven market verticals.
- Best Mobile Innovation for Smart Cities in Asia
4YFN Award Shanghai 2019: The innovation platform for MWC, 4YFN (4 Years From Now) enables startups, investors, corporations and public institutions to create and launch new ventures, strengthening the entrepreneurial ecosystem. This category recognises organisations that are accelerating business development and investment within the start-up community.
- 4YFN Award Shanghai 2019
Social Good: This category honours mobile innovations in the Asia region that contribute to achieving the United Nations Sustainable Development Goals (SDGs), a 17-point plan focused on ending poverty, protecting the planet and fighting injustice and inequality.
- Outstanding Mobile Contribution to the UN SDGs in Asia
Outstanding Achievement: This category celebrates individuals and organisations that have made a remarkable contribution to the digital community across the following areas:
- Outstanding Contribution to the Asia Mobile Industry (not open for entry)
- Women4Tech – Asian Industry Leadership Award
Details on Entering the AMO Awards
The AMO Awards 2019 are open to companies and individuals across the broad mobile ecosystem. The awards will be judged by independent experts, analysts, journalists, academics and, in some cases, mobile operator representatives. Select awards will be nominated by judges or by an independent panel of experts and will not be open for online entry. The submission of video to support entries is strongly encouraged by the awards judges.
Complete information on the AMO Awards, including the full list of categories, award criteria and deadlines, can be found at www.mwcshanghai.com/conference-programmes/asia-mobile-awards/ . Entries for the AMO Awards close on Wednesday, 10 April 2019 and the GSMA will announce the shortlist of nominations for each category by the end of May.
Get Involved at MWC19 Shanghai
For more information on MWC19 Shanghai, including how to attend, exhibit, partner or sponsor, visit www.mwcshanghai.com . Follow developments and updates on MWC19 Shanghai through our social media channels – follow us on Twitter at @GSMA and use #MWC19, get regular updates through our LinkedIn Showcase Page at www.linkedin.com/showcase/mwcshanghai/ , and follow us on Facebook at www.facebook.com/mwcshanghai . In China, you can follow us on Sina Weibo http://weibo.com/mwcshanghai or search “GSMA_MWCS” in WeChat.
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190129005049/en/
Contact:
For the GSMA April Tsui +852 2533 9956 atsui@webershandwick.com
Beau Bass +44 79 7662 4962 beau.bass@webershandwick.com
GSMA Press Office pressoffice@gsma.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom